An MMP-13-sensitive peptide with thiol groups was incorporated into the hydrogel, enabling on-demand drug release and degradation in response to overexpressed MMP-13 in the osteoarthritis microenvironment, to alleviate disease progression. Here, MMP13 is linked to osteoarthritis.